These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 12901099)

  • 1. [Antitumor effect of lidamycin-containing monoclonal antibody immunoconjugate with downsized-molecule].
    Liu XY; Zhen YS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):563-7. PubMed ID: 12901099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the antitumor activities of immunoconjugates composed of lidamycin and monoclonal antibody fab' fragment with different linkers].
    Feng Y; Shao RG; Dai Y; Li BW; He HW; Ren KH
    Yao Xue Xue Bao; 2010 May; 45(5):571-5. PubMed ID: 20931757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antitumor effects of the immunoconjugate composed of lidamycin and monoclonal antibody 3G11].
    Wang FQ; Shang BY; Zhen YS
    Yao Xue Xue Bao; 2003 Jul; 38(7):515-9. PubMed ID: 14515796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effects of the molecule-downsized immunoconjugate composed of lidamycin and Fab' fragment of monoclonal antibody directed against type IV collagenase.
    Fengqiang W; Boyang S; Yongsu Z
    Sci China C Life Sci; 2004 Feb; 47(1):66-73. PubMed ID: 15382678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor effect of the immunoconjugate composed of antibiotic C1027 and Fab fragment from a monoclonal antibody directed against human hepatoma].
    Li JZ; Jiang M; Xue YC; Zhen YS
    Yao Xue Xue Bao; 1993; 28(4):260-5. PubMed ID: 8213168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of the growth of hepatoma and hepatic metastasis by pingyangmycin conjugated with Fab' fragment of monoclonal antibody].
    Liu X; Shang B; Liu X
    Zhonghua Yi Xue Za Zhi; 2001 Feb; 81(4):201-4. PubMed ID: 11798873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antitumor activities of various immunoconjugates composed of lidamycin and anti-type IV collagenase monoclonal antibody].
    Feng Y; Zhen YS; Dai Y; Shang BY; Zhang M; He HW; Li BW; Shao RG
    Yao Xue Xue Bao; 2007 Jul; 42(7):704-9. PubMed ID: 17882952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of anti-type IV collagenase monoclonal antibody and its lidamycin conjugate against colon carcinoma.
    Li L; Huang YH; Li Y; Wang FQ; Shang BY; Zhen YS
    World J Gastroenterol; 2005 Aug; 11(29):4478-83. PubMed ID: 16052675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effects of the immunoconjugate composed of anti-type IV collagenase antibody Fab' fragment and lidamycin on tumor invasion and metastasis].
    Feng Y; He HW; Li BW; Zhang ZX; Chen X; Li XF
    Yao Xue Xue Bao; 2011 Dec; 46(12):1462-5. PubMed ID: 22375419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of monoclonal antibody Fab' fragment-containing immunoconjugates.
    Liu X; Zhen Y
    Chin Med Sci J; 2002 Mar; 17(1):1-6. PubMed ID: 12894876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biodistribution of monoclonal antibody and Fab fragment and antitumor effect of their conjugates on hepatoma xenografts].
    Li J; Zhen Y; Yang Z
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Oct; 16(5):328-33. PubMed ID: 7720121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific cytotoxicity of a human immunoglobulin-directed Fab'-ricin A chain conjugate.
    Raso V; Griffin T
    J Immunol; 1980 Dec; 125(6):2610-6. PubMed ID: 7430640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effect of lidamycin on growth of colon carcinoma 26 and hepatic metastasis in mice].
    Liu XJ; Dai Y; Shang Y; Li Y; Zhen YS
    Ai Zheng; 2005 Jun; 24(6):641-5. PubMed ID: 15946470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effects of an engineered and energized fusion protein consisting of an anti-CD20 scFv fragment and lidamycin.
    Fang H; Miao Q; Zhang S; Cheng X; Xiong D; Zhen Y
    Sci China Life Sci; 2011 Mar; 54(3):255-62. PubMed ID: 21416325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
    Chen J; Ouyang ZG; Zhang SH; Zhen YS
    Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule.
    Huang YH; Shang BY; Zhen YS
    World J Gastroenterol; 2005 Jul; 11(26):3980-4. PubMed ID: 15996019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antitumor activity of new antitumor antibiotic C1027 and its monoclonal antibody assembled conjugate].
    Shao RG; Zhen YS
    Yao Xue Xue Bao; 1992; 27(7):486-91. PubMed ID: 1442079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lidamycin inhibits the cancer cell PKC activity induced by basic fibroblast growth factor.
    Zhen HY; Huang YH; Zhen YS
    Yao Xue Xue Bao; 2005 Dec; 40(12):1110-5. PubMed ID: 16496675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lidamycin induces apoptosis of human gastric carcinoma BGC823 cells and inhibits xenograft growth in nude mice].
    Zhang SH; Chen J; Jiang M; Zhen YS
    Yao Xue Xue Bao; 2008 Jun; 43(6):601-4. PubMed ID: 18822962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.
    Cheng WW; Allen TM
    J Control Release; 2008 Feb; 126(1):50-8. PubMed ID: 18068849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.